Skip header and navigation

4 records – page 1 of 1.

Country food consumption in Yukon, Northwest Territories and Nunavut, Foodbook study 2014-2015.

https://arctichealth.org/en/permalink/ahliterature306492
Source
Can Commun Dis Rep. 2021 Jan 29; 47(1):30-36
Publication Type
Journal Article
Date
Jan-29-2021
Author
Vanessa Morton
Anna Manore
Nadia Ciampa
Shiona Glass-Kaastra
Matt Hurst
Angie Mullen
Jennifer Cutler
Author Affiliation
Outbreak Management Division, Public Health Agency of Canada, Guelph, ON.
Source
Can Commun Dis Rep. 2021 Jan 29; 47(1):30-36
Date
Jan-29-2021
Language
English
Publication Type
Journal Article
Abstract
This article presents a descriptive summary of the consumption of various country food (i.e. locally harvested plant and animal foods) products by residents of Yukon (YT), Northwest Territories (NT) and Nunavut (NU). Data were collected as part of the Foodbook study in 2014-2015.
The Foodbook study was conducted by telephone over a one-year period. Respondents were asked about consumption of a wide range of food products over the previous seven days. Residents of the territories were also asked about consumption of regionally-specific country food. Data were weighted to develop territorial estimates of consumption. Data on age, gender, location, income and education were also collected.
The national response rate for the Foodbook survey was 19.9%. In total, 1,235 residents of the territories participated in the study (YT, n=402; NT, n=458; NU, n=375). Consumption of any country food during the previous seven days was reported by 77.5%, 60.7%, and 66.4% of participants in NU, NT and YT, respectively.
Responses to country food questions asked alongside the main Foodbook questionnaire provide insight on country food consumption in YT, NT and NU.
PubMed ID
33679246 View in PubMed
Less detail

Laboratory characterization of invasive Haemophilus influenzae isolates from Nunavut, Canada, 2000-2012.

https://arctichealth.org/en/permalink/ahliterature279885
Source
Int J Circumpolar Health. 2016 Jan;75(1):29798
Publication Type
Article
Date
Jan-2016
Author
Raymond S W Tsang
Y Anita Li
Angie Mullen
Maureen Baikie
Kathleen Whyte
Michelle Shuel
Gregory Tyrrell
Jenny A L Rotondo
Shalini Desai
John Spika
Source
Int J Circumpolar Health. 2016 Jan;75(1):29798
Date
Jan-2016
Language
English
Publication Type
Article
Abstract
Background With invasive Haemophilus influenzae serotype b (Hib) disease controlled by vaccination with conjugate Hib vaccines, there is concern that invasive disease due to non-serotype b strains may emerge. Objective This study characterized invasive H. influenzae (Hi) isolates from Nunavut, Canada, in the post-Hib vaccine era. Methods Invasive H. influenzae isolates were identified by conventional methods at local hospitals; and further characterized at the provincial and federal public health laboratories, including detection of serotype antigens and genes, multi-locus sequence typing and antibiotic susceptibility. Results Of the 89 invasive H. influenzae cases identified from 2000 to 2012, 71 case isolates were available for study. There were 43 serotype a (Hia), 12 Hib, 2 Hic, 1 Hid, 1 Hie, 2 Hif and 10 were non-typeable (NT). All 43 Hia were biotype II, sequence type (ST)-23. Three related STs were found among the Hib isolates: ST-95 (n=9), ST-635 (n=2) and ST-44 (n=1). Both Hif belonged to ST-124 and the 2 Hic were typed as ST-9. The remaining Hid (ST-1288) and Hie (ST-18) belonged to 2 separate clones. Of the 10 NT strains, 3 were typed as ST-23 and the remaining 7 isolates each belonged to a unique ST. Eight Hib and 1 NT-Hi were found to be resistant to ampicillin due to ?-lactamase production. No resistance to other antibiotics was detected. Conclusion During the period of 2000-2012, Hia was the predominant serotype causing invasive disease in Nunavut. This presents a public health concern due to an emerging clone of Hia as a cause of invasive H. influenzae disease and the lack of published guidelines for the prophylaxis of contacts. The clonal nature of Hia could be the result of spread within an isolated population, and/or unique characteristics of this strain to cause invasive disease. Further study of Hia in other populations may provide important information on this emerging pathogen. No antibiotic resistance was detected among Hia isolates; a small proportion of Hib and NT-Hi isolates demonstrated resistance to ampicillin due to ?-lactamase production.
PubMed ID
28156415 View in PubMed
Less detail

Laboratory characterization of invasive Haemophilus influenzae isolates from Nunavut, Canada, 2000-2012.

https://arctichealth.org/en/permalink/ahliterature269164
Source
Int J Circumpolar Health. 2016;75:29798
Publication Type
Article
Date
2016
Author
Raymond S W Tsang
Y Anita Li
Angie Mullen
Maureen Baikie
Kathleen Whyte
Michelle Shuel
Gregory Tyrrell
Jenny A L Rotondo
Shalini Desai
John Spika
Source
Int J Circumpolar Health. 2016;75:29798
Date
2016
Language
English
Publication Type
Article
Abstract
With invasive Haemophilus influenzae serotype b (Hib) disease controlled by vaccination with conjugate Hib vaccines, there is concern that invasive disease due to non-serotype b strains may emerge.
This study characterized invasive H. influenzae (Hi) isolates from Nunavut, Canada, in the post-Hib vaccine era.
Invasive H. influenzae isolates were identified by conventional methods at local hospitals; and further characterized at the provincial and federal public health laboratories, including detection of serotype antigens and genes, multi-locus sequence typing and antibiotic susceptibility.
Of the 89 invasive H. influenzae cases identified from 2000 to 2012, 71 case isolates were available for study. There were 43 serotype a (Hia), 12 Hib, 2 Hic, 1 Hid, 1 Hie, 2 Hif and 10 were non-typeable (NT). All 43 Hia were biotype II, sequence type (ST)-23. Three related STs were found among the Hib isolates: ST-95 (n=9), ST-635 (n=2) and ST-44 (n=1). Both Hif belonged to ST-124 and the 2 Hic were typed as ST-9. The remaining Hid (ST-1288) and Hie (ST-18) belonged to 2 separate clones. Of the 10 NT strains, 3 were typed as ST-23 and the remaining 7 isolates each belonged to a unique ST. Eight Hib and 1 NT-Hi were found to be resistant to ampicillin due to ?-lactamase production. No resistance to other antibiotics was detected.
During the period of 2000-2012, Hia was the predominant serotype causing invasive disease in Nunavut. This presents a public health concern due to an emerging clone of Hia as a cause of invasive H. influenzae disease and the lack of published guidelines for the prophylaxis of contacts. The clonal nature of Hia could be the result of spread within an isolated population, and/or unique characteristics of this strain to cause invasive disease. Further study of Hia in other populations may provide important information on this emerging pathogen. No antibiotic resistance was detected among Hia isolates; a small proportion of Hib and NT-Hi isolates demonstrated resistance to ampicillin due to ?-lactamase production.
PubMed ID
26765260 View in PubMed
Less detail

Summary of available surveillance data on hepatitis C virus infection from eight Arctic countries, 2012 to 2014.

https://arctichealth.org/en/permalink/ahliterature295354
Source
Euro Surveill. 2018 Oct; 23(40):
Publication Type
Journal Article
Date
Oct-2018
Author
Prabhu P Gounder
Anders Koch
Ginger Provo
Astrid Lovlie
Josefine Lundberg Ederth
Maria Axelsson
Chris P Archibald
Brendan Hanley
Angie Mullen
Myrna Matheson
David Allison
Henrik Trykker
Thomas W Hennessy
Markku Kuusi
Vladimir Chulanov
Brian J McMahon
Author Affiliation
Arctic Investigations Program, Division of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Diseases, U.S. Centers for Disease Control and Prevention (CDC), Anchorage, Alaska, USA.
Source
Euro Surveill. 2018 Oct; 23(40):
Date
Oct-2018
Language
English
Publication Type
Journal Article
Abstract
We summarised available hepatitis C virus (HCV) surveillance data for 2012-14 from Arctic/sub-Arctic countries/regions. We sent a HCV data collection template by email to public health authorities in all jurisdictions. Population statistics obtained from census sources for each country were used to estimate rates of reported acute and chronic/undifferentiated HCV cases. Seven countries with Arctic regions (Canada, Denmark, Finland, Greenland, Norway, Sweden and the United States, represented by the state of Alaska), including three Canadian territories and one province, as well as 11 Russian subnational Arctic regions, completed the data collection template. Data on acute HCV infection during 2014 was available from three Arctic countries and all Russian Arctic regions (rate range 0/100,000 population in Greenland, as well as Nenets and Chukotka Automous Okrugs (Russian subnational Arctic regions) to 3.7/100,000 in the Russian Republic of Komi). The rate of people with chronic/undifferentiated HCV infection in 2014 ranged from 0/100,000 in Greenland to 171.2/100,000 in Alaska. In most countries/regions, the majority of HCV-infected people were male and aged 19-64 years. Differences in surveillance methods preclude direct comparisons of HCV surveillance data between Arctic countries/regions. Our data can inform future efforts to develop standardised approaches to HCV surveillance in the Arctic countries/regions by identifying similarities/differences between the surveillance data collected.
Notes
Cites: Lancet. 2011 Aug 13;378(9791):571-83 PMID 21802134
Cites: Addict Sci Clin Pract. 2013 Dec 13;8:20 PMID 24330568
Cites: Euro Surveill. 2008 May 22;13(21):null PMID 18761967
Cites: Lancet Infect Dis. 2016 Dec;16(12):1409-1422 PMID 27615026
Cites: Int J Circumpolar Health. 2013 Jul 17;72:null PMID 23971016
Cites: Ann Intern Med. 2014 Mar 4;160(5):293-300 PMID 24737271
Cites: Alaska Med. 2007;49(2 Suppl):193-203 PMID 17929632
Cites: J Viral Hepat. 2014 May;21 Suppl 1:60-89 PMID 24713006
Cites: Euro Surveill. 2015 Apr 02;20(13):17-24 PMID 25860392
Cites: MMWR Morb Mortal Wkly Rep. 2015 May 8;64(17):453-8 PMID 25950251
Cites: Harm Reduct J. 2013 May 07;10:7 PMID 23651646
Cites: J Hepatol. 2014 Nov;61(1 Suppl):S45-57 PMID 25086286
Cites: Emerg Infect Dis. 2008 Jan;14(1):18-24 PMID 18258072
Cites: Hepatology. 2013 Apr;57(4):1333-42 PMID 23172780
PubMed ID
30301489 View in PubMed
Less detail